ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant Cancers
能有效降解ATG13的ULK1/2抑制剂可靶向KRAS突变型癌症
期刊:
影响因子:
doi:10.1101/2025.10.14.682402
Hagan, Patrick M; Ren, Huiyu; Brun, Sonja N; Layng, Fabiana I A; Panickar, Dhanya R; Lambert, Lester J; Celeridad, Maria; Das, Ranajit; Ling, Li; Zhang, Yijuan; Limpert, Allison S; Sheffler, Douglas J; Commisso, Cosimo; Shaw, Reuben J; Cosford, Nicholas D P